Search clinical trials for: neurology

Total 3119 results

Genzyme, a Sanofi Company

Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Fabry Disease

United States, France, Netherlands, Puerto Rico, United Kingdom
Isarna Therapeutics GmbH

Completed

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Glioblastoma | Anaplastic Astrocytoma

Germany, Austria, Georgia, India, Israel, Russian Federation
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)

Behavioral Symptoms | Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Behavioral Symptoms | Autistic Disorder

United States
Centro Hospitalar de Entre o Douro e Vouga

Completed

Stroke Wearable Operative Rehabilitation Device Impact Trial (SWORD-IT)

Ischemic Stroke | Upper Extremity Hemiparesis

Portugal
Changhua Christian Hospital

Completed

Genetic Polymorphism and Parkinson's Disease in Taiwanese

Parkinson's Disease

Taiwan
Sunovion

Completed

Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression (PREVAIL3)

Bipolar Depression

United States, Canada, Colombia, Czech Republic, India, Japan, Lithuania, Peru, Slovakia, Ukraine
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

Alzheimer's Disease

United States, Germany, Canada, Austria
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

Alzheimer's Disease

United States
PhotoThera, Inc

Completed

Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3) (NEST-3)

Acute Ischemic Stroke

United States, Switzerland, Canada, Spain, Germany, Peru, Austria, Finland, France, Sweden
Boehringer Ingelheim

Completed

Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

Parkinson Disease

United States, Canada
Tehran University of Medical Sciences

Completed

The Effect of GCSF in the Treatment of ALS Patients

Amyotrophic Lateral Sclerosis

Iran, Islamic Republic of
University Hospital, Toulouse
Fondation de France

Completed

Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy (MSA-DOUL)

Multiple System Atrophy | Pain Threshold

France
Boehringer Ingelheim

Completed

Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)

Restless Legs Syndrome

United States
FUJIFILM Toyama Chemical Co., Ltd.

Completed

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States, Canada
Lawson Health Research Institute
Consortium of Canadian Centres for Clinical Cognitive Research

Completed

Safety Study of Intranasal Oxytocin in Frontotemporal Dementia (FTDOXY10EF)

Frontotemporal Dementia

Canada
Capnia, Inc.
United States Naval Medical Center, San Diego; Walter Reed National Military... and other collaborators

Terminated

The Effect of Nasal Carbon Dioxide in the Treatment of Moderate to Severe Migraine

Migraine

United States
Japan Foundation for Neuroscience and Mental Health
National Center of Neurology and Psychiatry, Japan

Completed

A Community Intervention Trial of Multimodal Suicide Prevention Program in Japan (NOCOMIT-J) (NOCOMIT-J)

Suicide

Japan
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

Multiple Sclerosis

United States
Newron Pharmaceuticals SPA

Completed

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist (MOTION)

Idiopathic Parkinson's Disease

United States, Spain, Brazil, Peru, Colombia, Germany, Argentina, India, Croatia, Czech Republic, Italy, South Africa, Finland, Portugal, Canada, Slovakia, Bulgaria, Chile, Mexico, Poland
Boehringer Ingelheim

Completed

Efficacy and Tolerability CVI (A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial (CVI)

Venous Insufficiency

Germany, Austria, Czech Republic
Boehringer Ingelheim

Completed

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Parkinson Disease

United States, Canada
Boehringer Ingelheim

Completed

A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations

Parkinson Disease

Spain, Germany, France, Austria, United Kingdom, Netherlands
Boehringer Ingelheim

Completed

An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type

Alzheimer Disease

United States, Canada
Vanderbilt University

Completed

Study to Assess the Changes in Blood Clotting Factors and Blood Vessel Wall Function in Obstructive Sleep Apnea

Obstructive Sleep Apnea

United States
Photocure

Completed

Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy

Bladder Cancer

United States, Canada, Austria, Germany, Netherlands
University Hospital Muenster
German Federal Ministry of Education and Research

Completed

Dopaminergic Enhancement of Learning and Memory in Aphasia

Aphasia | Cerebrovascular Accident

Germany
Biogen

Completed

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

Relapsing-remitting Multiple Sclerosis

Belgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
Bispebjerg Hospital

Completed

Motor Response to Sildenafil in PD

Erectile Dysfunction | Parkinsons Disease

Denmark
Campus Bio-Medico University

Unknown

Extremely Low Frequency Magnetic Fields in Acute Ischemic Stroke

Stroke

Italy
Jinling Hospital, China

Unknown

Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis

Cerebrovascular Disease

China
Acorda Therapeutics

Completed

Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis

Multiple Sclerosis

United States
European Institute for Evidence Based Osteopathic...

Completed

Clinical Effectiveness of Osteopathic Manipulative Treatment in Chronic Migraine

Migraine

Italy
Celgene Corporation

Terminated

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 (CRPS-002)

Complex Regional Pain Syndrome, Type I

United States
Novartis

Completed

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 (ACTION)

Alzheimer's Disease

United States, Puerto Rico
Charite University, Berlin, Germany
German Federal Ministry of Education and Research

Unknown

Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation (CATS)

Post-Stroke Chronic Aphasia | Anomia (Word-retrieval Impairment)

Germany
Richard Barohn, MD

Completed

Effectiveness of Mexiletine for Treating People With Non-Dystrophic Myotonia

Non-Dystrophic Myotonia | Myotonia

United States, Canada, Italy, United Kingdom
Charite University, Berlin, Germany
German Research Foundation

Completed

Impact of Transcranial Direct Current Stimulation on Language Functions in Mild Cognitive Impairment (STIMCI)

Mild Cognitive Impairment

Germany
Shanghai Rxmidas Pharmaceuticals Co. Ltd.
Gedeon Richter Ltd.

Completed

Chinese Assessment for Vinpocetine In Neurology (CAVIN)

Cerebral Infarction

China
University Hospital, Martin

Unknown

Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke (Heparinas)

Acute Ischemic Stroke

Slovakia
University of Manitoba
Winnipeg Regional Health Authority

Unknown

18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology

Tumors

Canada
Guangzhou University of Traditional Chinese Medicine

Completed

AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine

Cerebral Infarction

China
Shahid Beheshti University of Medical Sciences

Completed

Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment

Migraine Without Aura | Migraine With Aura

Iran, Islamic Republic of
Kai Bötzel
Medtronic; Lueneburg Heritage

Unknown

Basal Ganglia Local Field Potentials in Gait and Speech

Basal Ganglia Diseases

Germany
Cephalon

Completed

Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness

Narcolepsy | Excessive Daytime Sleepiness | Chronic Shift Work Sleep Disorder | Obstructive Sleep Apnea/Hypopnea Syndrome

United States, Australia, Canada, France, Puerto Rico, Germany, Russian Federation
Cephalon

Completed

Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression

Obstructive Sleep Apnea | Major Depressive Disorder | Sleep Disorders | Dysthymic Disorder

United States
Cephalon

Completed

Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Narcolepsy | Excessive Daytime Sleepiness | Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)

United States
Cephalon

Completed

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Sleep Apnea Syndromes | Sleep Apnea, Obstructive | Narcolepsy | Shift-Work Sleep Disorder

United States, Russian Federation
Danish Headache Center

Completed

Acetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow

Migraine | Headache

Denmark

Search clinical trials for: neurology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations